The rating downgrade reflects inpatient volume contractions through fiscal year 2015.
The outlook is negative, reflecting potential forthcoming rating pressure if EJGH’s efforts to increase volumes and revenue fall through.
More articles on healthcare finance:
AHA weighs in on CMS’ proposed drug payment model
Moody’s downgrades CHI’s rating to ‘A3’
Moody’s assigns ‘A1’ rating to Memorial Hermann Health System’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
